• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于控制药物释放的层层涂覆多孔 3D 打印羟基磷灰石复合支架。

Layer-by-layer coated porous 3D printed hydroxyapatite composite scaffolds for controlled drug delivery.

机构信息

Advanced Biomaterials and Tissue Engineering Center, Huazhong University of Science and Technology, Wuhan, 430074, China.

Advanced Biomaterials and Tissue Engineering Center, Huazhong University of Science and Technology, Wuhan, 430074, China; Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, China.

出版信息

Colloids Surf B Biointerfaces. 2019 Jul 1;179:121-127. doi: 10.1016/j.colsurfb.2019.03.063. Epub 2019 Mar 28.

DOI:10.1016/j.colsurfb.2019.03.063
PMID:30954012
Abstract

Interconnected porous scaffolds are widely used in the applications of tissue repair and regeneration. Sustained local delivery of drugs and growth factors around the implanted scaffolds could accelerate the growth of cells and contribute to the regeneration of damaged tissues. In this study, porous hydroxyapatite composite scaffolds were prepared through 3D bio-printing for bone tissue engineering and were subsequently coated with chitosan and sodium hyaluronate by layer-by-layer (LBL) deposition. It was found that the LBL coating on the porous scaffolds could reduce the swelling ratio of scaffolds in size and increase the compressive strength by about 70%. The degradation rate of the scaffolds slowed down due to the LBL coating. Rhodamine B (RHB) and bovine serum albumin (BSA) were chosen as model drugs in order to understand the loading and release behaviors of the scaffolds. Small RHB molecules could penetrate deep into the LBL coated scaffolds and released a little slower than that without coating. Meanwhile, large BSA molecules showed faster release rate compared to that without coating. In addition, there was no significant cytotoxicity effect of these composite scaffolds towards MC-3T3E1 cells and the scaffolds provided proper conditions for cell adhesion and proliferation, indicating that the printed hydroxyapatite composite scaffolds exhibit a great potential in hard tissue engineering as a sustained delivery system.

摘要

多孔互联支架广泛应用于组织修复和再生领域。在植入支架周围持续局部输送药物和生长因子可以加速细胞的生长,促进受损组织的再生。在这项研究中,通过 3D 生物打印制备了用于骨组织工程的多孔羟基磷灰石复合支架,随后通过层层(LBL)沉积对其进行壳聚糖和透明质酸钠的涂层处理。研究发现,多孔支架的 LBL 涂层可以将支架的溶胀率降低约 70%,同时增加其压缩强度。由于 LBL 涂层的存在,支架的降解速度也会减慢。本研究选择了罗丹明 B(RHB)和牛血清白蛋白(BSA)作为模型药物,以了解支架的载药和释放行为。小分子 RHB 可以深入渗透到 LBL 涂层的支架中,释放速度比没有涂层的支架稍微慢一些。同时,大分子 BSA 的释放速度比没有涂层的支架更快。此外,这些复合支架对 MC-3T3E1 细胞没有明显的细胞毒性作用,并且为细胞黏附和增殖提供了适当的条件,这表明打印的羟基磷灰石复合支架作为一种持续释放系统,在硬组织工程中有很大的应用潜力。

相似文献

1
Layer-by-layer coated porous 3D printed hydroxyapatite composite scaffolds for controlled drug delivery.用于控制药物释放的层层涂覆多孔 3D 打印羟基磷灰石复合支架。
Colloids Surf B Biointerfaces. 2019 Jul 1;179:121-127. doi: 10.1016/j.colsurfb.2019.03.063. Epub 2019 Mar 28.
2
Evaluation of BMP-2 and VEGF loaded 3D printed hydroxyapatite composite scaffolds with enhanced osteogenic capacity in vitro and in vivo.评价负载 BMP-2 和 VEGF 的 3D 打印羟基磷灰石复合支架的体外和体内增强成骨能力。
Mater Sci Eng C Mater Biol Appl. 2020 Jul;112:110893. doi: 10.1016/j.msec.2020.110893. Epub 2020 Mar 21.
3
Immobilization of salvianolic acid B-loaded chitosan microspheres distributed three-dimensionally and homogeneously on the porous surface of hydroxyapatite scaffolds.载有丹酚酸B的壳聚糖微球三维均匀地固定在羟基磷灰石支架的多孔表面上。
Biomed Mater. 2016 Oct 7;11(5):055014. doi: 10.1088/1748-6041/11/5/055014.
4
Modified n-HA/PA66 scaffolds with chitosan coating for bone tissue engineering: cell stimulation and drug release.用于骨组织工程的壳聚糖涂层改性n-HA/PA66支架:细胞刺激与药物释放
J Biomater Sci Polym Ed. 2017 Sep;28(13):1271-1285. doi: 10.1080/09205063.2017.1318029. Epub 2017 Apr 21.
5
Improvement of mechanical strength and osteogenic potential of calcium sulfate-based hydroxyapatite 3-dimensional printed scaffolds by ε-polycarbonate coating.通过ε-聚碳酸酯涂层提高硫酸钙基羟基磷灰石三维打印支架的机械强度和成骨潜力。
J Biomater Sci Polym Ed. 2017 Sep;28(13):1256-1270. doi: 10.1080/09205063.2017.1312059. Epub 2017 Jun 21.
6
Surface modification of 3D-printed porous scaffolds via mussel-inspired polydopamine and effective immobilization of rhBMP-2 to promote osteogenic differentiation for bone tissue engineering.通过受贻贝启发的聚多巴胺对3D打印多孔支架进行表面改性以及有效固定重组人骨形态发生蛋白-2以促进骨组织工程中的成骨分化
Acta Biomater. 2016 Aug;40:182-191. doi: 10.1016/j.actbio.2016.02.006. Epub 2016 Feb 8.
7
Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2.含有壳聚糖微球的多孔纳米羟基磷灰石/胶原蛋白/聚乳酸支架用于BMP-2衍生合成肽的控释。
J Control Release. 2009 Mar 4;134(2):111-7. doi: 10.1016/j.jconrel.2008.11.020. Epub 2008 Dec 3.
8
The influence hydroxyapatite nanoparticle shape and size on the properties of biphasic calcium phosphate scaffolds coated with hydroxyapatite-PCL composites.羟基磷灰石纳米颗粒的形状和尺寸对羟基磷灰石-PCL 复合材料涂层双相磷酸钙支架性能的影响。
Biomaterials. 2010 Jul;31(21):5498-509. doi: 10.1016/j.biomaterials.2010.03.058. Epub 2010 Apr 15.
9
3D printing of layered mesoporous bioactive glass/sodium alginate-sodium alginate scaffolds with controllable dual-drug release behaviors.3D 打印具有可控双重药物释放行为的层状介孔生物活性玻璃/海藻酸钠-海藻酸钠支架。
Biomed Mater. 2019 Oct 3;14(6):065011. doi: 10.1088/1748-605X/ab4166.
10
Development of hydroxyapatite bone scaffold for controlled drug release via poly(epsilon-caprolactone) and hydroxyapatite hybrid coatings.通过聚(ε-己内酯)和羟基磷灰石混合涂层制备用于控释药物的羟基磷灰石骨支架。
J Biomed Mater Res B Appl Biomater. 2004 Aug 15;70(2):240-9. doi: 10.1002/jbm.b.30038.

引用本文的文献

1
The application of tissue engineering strategies for uterine regeneration.组织工程策略在子宫再生中的应用。
Mater Today Bio. 2025 Feb 18;31:101594. doi: 10.1016/j.mtbio.2025.101594. eCollection 2025 Apr.
2
3D-printed silicon nitride ceramic implants for clinical applications: the state of the art and prospects.用于临床应用的3D打印氮化硅陶瓷植入物:现状与展望
RSC Adv. 2025 Jan 3;15(1):406-419. doi: 10.1039/d4ra07970a. eCollection 2025 Jan 2.
3
Recent advances in layer-by-layer assembly scaffolds for co-delivery of bioactive molecules for bone regeneration: an updated review.
近年来,用于骨再生的生物活性分子共递送的层层组装支架的研究进展:更新综述。
J Transl Med. 2024 Nov 5;22(1):1001. doi: 10.1186/s12967-024-05809-0.
4
An osteoinductive and biodegradable intramedullary implant accelerates bone healing and mitigates complications of bone transport in male rats.一种具有成骨诱导性和可生物降解性的髓内植入物可加速雄性大鼠的骨愈合并减轻骨搬运的并发症。
Nat Commun. 2023 Jul 24;14(1):4455. doi: 10.1038/s41467-023-40149-5.
5
Polysaccharide-based biomaterials in a journey from 3D to 4D printing.基于多糖的生物材料:从3D打印到4D打印的历程
Bioeng Transl Med. 2023 Mar 22;8(4):e10503. doi: 10.1002/btm2.10503. eCollection 2023 Jul.
6
Strategies To Modify the Surface and Bulk Properties of 3D-Printed Solid Scaffolds for Tissue Engineering Applications.用于组织工程应用的3D打印固体支架表面和整体性质的改性策略。
ACS Omega. 2023 Jan 30;8(6):5139-5156. doi: 10.1021/acsomega.2c05984. eCollection 2023 Feb 14.
7
Design strategies for composite matrix and multifunctional polymeric scaffolds with enhanced bioactivity for bone tissue engineering.用于骨组织工程的具有增强生物活性的复合基质和多功能聚合物支架的设计策略。
Front Chem. 2022 Nov 28;10:1051678. doi: 10.3389/fchem.2022.1051678. eCollection 2022.
8
Calcium Phosphate-Based Bioceramics in the Treatment of Osteosarcoma: Drug Delivery Composites and Magnetic Hyperthermia Agents.基于磷酸钙的生物陶瓷在骨肉瘤治疗中的应用:药物递送复合材料与磁热疗剂
Front Med Technol. 2021 Jun 30;3:700266. doi: 10.3389/fmedt.2021.700266. eCollection 2021.
9
A Nanofiber Mat With Dual Bioactive Components and a Biomimetic Matrix Structure for Improving Osteogenesis Effect.一种具有双生物活性成分和仿生基质结构以提高成骨效果的纳米纤维垫。
Front Chem. 2021 Oct 29;9:740191. doi: 10.3389/fchem.2021.740191. eCollection 2021.
10
Formulation and Characterization of Alginate Dialdehyde, Gelatin, and Platelet-Rich Plasma-Based Bioink for Bioprinting Applications.用于生物打印应用的基于海藻酸钠二醛、明胶和富血小板血浆的生物墨水的配方与表征
Bioengineering (Basel). 2020 Sep 9;7(3):108. doi: 10.3390/bioengineering7030108.